Neurological aspects of eclampsia

Journal of the Neurological Sciences

Volumn 155, Issue 1, 1998, Pages 37-43

  Thomas, Sanjeev V ^a  

^a ROYAL HOSPITAL   (Oman)

Author keywords

Eclampsia; Hypertension in pregnancy; Hypertensive encephalopathy; Seizures in pregnancy

Indexed keywords

DIAZEPAM; PHENYTOIN;

ARTICLE; BRAIN DYSFUNCTION; BRAIN EDEMA; COMA; COMPUTER ASSISTED TOMOGRAPHY; ECLAMPSIA; ELECTROENCEPHALOGRAM; EPILEPTIC DISCHARGE; FEMALE; HUMAN; HYPERTENSION ENCEPHALOPATHY; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PREECLAMPSIA; PRIORITY JOURNAL; SEIZURE; SENSORY SYSTEM; VASCULAR DISEASE;

EID: 0032542490     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)00274-8     Document Type: Review

References (49)

1. Aur L.M. The pathogenesis of hypertensive encephalopathy: experimental data and their clinical relevance with special reference to neurosurgical patients. Acta Neurochirur. 27:1978;1-111.
2. Belfort M.A., Moise K.J. Jr. Effect of magnesium sulfate on maternal brain blood flow in pre-eclampsia: a randomized, placebo controlled study. Am. J. Obstet. Gynecol. 167:1992;661-666.
3. Brophy E., Brophy M.H. Pyridoxal phosphate normalization of the EEG in eclampsia. Electroencephalogr. Clin. Neurophysiol. 79:1991;36P.
4. Cotton D.B., Hallak M., Janusz C., Irtenkauf S.M., Berman R.F. Central anticonvulsant effects of magnesium sulfate on N-methyl D-aspartate-induced seizures. Am. J. Obstet. Gynecol. 168:1993;974-978.
5. Davey D.A., MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am. J. Obstet. Gynecol. 158:1988;892-898.
6. Dickens B.F., Weglicki Y., Li S., Mak I.T. Magnesium deficiency in vitro enhances free radical induced intracellular oxidation and cytotoxicity in endothelial cells. FEBS Lett. 311:1992;187-191.
7. Dierckx I., Appel B. MR findings in eclampsia. Am. J. Neuroradiol. 10:1989;445.
8. Donaldson, J.D., 1995. Neurological disorders. In: de Swiet, M. (Ed.), Medical Disorders in Obstetric Practice, 3rd ed. Blackwell Science, London, pp. 535-551.
9. Duncan R., Hadley D., Bone I., Symonds E.M., Worthington B.S., Rubin P.C. Blindness in eclampsia: CT and MR imaging. J. Neurol. Neurosurg. Psychiatry. 52:1989;899-902.
10. Eclampsia Trial Collaborative Group, 1995. Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial. Lancet, 345, 1455-1463.
11. Fredriksson K., Lindvall O., Ingemarsson I., Astedt D., Conqvist S., Holtås S. Repeated cranial computed tomographic and magnetic resonance imaging scans in two cases of eclampsia. Stroke. 20:1989;547-553.
12. Hibbard L.T. Maternal mortality due to acute toxemia. Obstet. Gynecol. 42:1973;263-270.
13. Hinchey J., Chaves C., Appignani B., Breen J., Pao L., Wang A.et al. A reversible posterior leukoencephalopathy syndrome. N. Engl. J. Med. 334:1996;494-500.
14. Lazard E.M. A preliminary report on the intravenous use of magnesium sulfate in puerperal eclampsia. Am. J. Obstet. Gynecol. 9:1925;178-188.
15. Lean T.H., Ratnam S.S., Sivasamboo R. The use of benzodiazepines in the management of eclampsia. J. Obstet. Gynecol. Br. Commonw. 75:1968;856-862.
16. Lewis L.K., Hinshaw D.B. Jr., Will A.D., Hasso A.N., Thompson J.R. CT and angiographic correlation of severe neurologic disease in toxemia of pregnancy. Neuroradiology. 30:1988;59-64.
17. Llewellyn-Jones D. The treatment of eclampsia. J. Obstet. Gynecol. Br. Commonw. 68:1961;33-43.
18. Longo, V.G., 1977. Effects of drugs on EEG. In: Remond, A. (Ed.), Handbook of Electroencephalography and Clinical Neurophysiology. Elsevier, Amsterdam, 7C, pp. 1-132.
19. Lopez-Llera M. Eclampsia: 1963-1966. J. Obstet. Gynecol. Br. Commonw. 74:1967;379-384.
20. Lopez-Llera M., Linares G.R., Horta J.L.H. Maternal mortality rates in eclampsia. Am. J. Obstet. Gynecol. 124:1976;149-155.
21. Lucas M.J., DePalma R.T., Peters M.T., Leveno K.J., Person D., Cunningham F.G. A simplified phenytoin regimen for pre eclampsia. Am. J. Perinatol. 11:1994;153-156.
22. Lucas M.J., Leveno K.J., Cunningham F.G. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N. Engl. J. Med. 333:1995;201-205.
23. Malow B.A., Sandson T.A., Schwartz R.B. Reversible MRI lesions in eclampsia with hydatidiform mole. Neurology. 40:1990;1471-1472.
24. Menon M.K.K. The evolution in the treatment of eclampsia. J. Obstet. Gynecol. Br. Commonw. 68:1961;417-426.
25. McGiff J.C., Carroll M.A. Eicosanoids in preeclampsia-eclampsia: the effects of magnesium. Hypertens. Pregn. 13:1994;217-226.
26. Naidu S., Payne A.J., Moodley J., Hoffmann M., Gouws E. Randomised study assessing the effect of phenytoin and magnesium sulphate on maternal cerebral circulation in eclampsia using transcranial doppler ultrasound. Br. J Obstet. Gynecol. 103:1996;111-116.
27. Nelson K.B., Grether J.K. Can magnesium sulfate reduce the risk of cerebral palsy in very low birth weight infants. Pediatrics. 95:1995;263-269.
28. Pritchard J.A., Cunningham F.G., Pritchard S.A. The Parkland memorial hospital protocol for treatment of eclampsia, evaluation of 245 cases. Am. J. Obstet. Gynecol. 148:1984;951-963.
29. Raroque H.G. Jr., Orrison W.W., Rosenberg G.A. Neurologic involvement in toxemia of pregnancy: reversible MRI lesions. Neurology. 40:1990;167-169.
30. Richards A., Graham D., Bullock R. Clinicopathological study of neurological complications due to hypertensive disorders of pregnancy. J. Neurol. Neurosurg. Psychiatry. 51:1988;416-421.
31. Royston, E., Armstrong, S., 1989. Preventing Maternal Deaths. WHO, Geneva, pp. 75-106.
32. Sanders T.G., Clayman D.A., Sanches-Ramos L., Viner F.S., Russo L. Brain in eclampsia MR imaging with clinical correlations. Radiology. 180:1991;475-478.
33. Schwartz R.B., Jones K.M., Kalina P., Bajakian R.L., Montell M.T., Garada B.et al. Hypertensive encephalopathy: findings on CT, MR imaging and SPECT imaging in 14 cases. Am. J. Roentgenol. 159:1992;379-383.
34. Sheares, B.M., 1957. Combination of chlorpromazine, promazine, and pethidine in treatment of eclampsia. Br. Med. J. ii, 75.
35. Sheehan, H.L., Lynch, J.P., 1973. Pathology of toxemia in pregnancy. Churchill Livingstone, London, pp. 524-553.
36. Sibai B.M., McCubbin J.H., Anderson G.D., Lipshitz J., Dilts P.V. Eclampsia I: observations from 67 recent cases. Obstet. Gynecol. 58:1981;609-613.
37. Sibai B.M., Spinnato J.A., Watson D.L., Lewis J.A., Anderson G.D. Eclampsia IV: neurological findings and future outcome. Am. J. Obstet. Gynecol. 152:1985;184-192.
38. Sibai, B.M., Anderson, G.D., 1991. Eclampsia. In: Gabbe, S.G., Niebyl, J.R., Simpson, J.L. (Eds.), Obstetrics Normal and Problem Pregnancies. 2nd ed. Churchill Livingstone, New York, pp. 993-1055.
39. Sibai B.M., Ustav I.M. Emergent management of puerperal eclampsia. Obstet. Gynecol. Clin. North Am. 22:1995;315-335.
40. Sibai B.M. Treatment of hypertension in pregnant women. N. Engl. J. Med. 335:1996;257-265.
41. Sipes S.L., Weiner C.P., Gellhaus T.M., Goodspeed J.D. Effects of magnesium sulfate infusion upon plasma prostaglandins in preeclampsia and preterm labor. Hypertens. Pregn. 13:1994;293-302.
42. Thomas S.V., Somanathan N., Radhakumari R. Interictal EEG changes in eclampsia. Electroencephalogr. Clin. Neurophysiol. 94:1995;271-275.
43. Thomas S.V., Somanathan N., Rao V.R.K., Radhakurmari K. Reversible non-enhancing lesions without focal neurological deficits in eclampsia. Indian J. Med. Res. 103:1996;94-97.
44. Trommer B.L., Homer D., Mikhael M.A. Cerebral vasospasm and eclampsia. Stroke. 19:1988;326-329.
45. Van Assche F.A., Spitz B., Vansteelant L. Severe systemic hypertension during pregnancy. Am. J. Cardiol. 63:1989;22c-25c.
46. Vandenplas O., Dive A., Dooms G., Mathieu P. Magnetic resonance evaluation of severe neurological disorders in eclampsia. Neuroradiology. 32:1990;47-49.
47. Will A.D., Lewis K.L., Hinshaw D.B. Jr., Jordan K., Cousins L.M., Hasso A.N., Thompson J.R. Cerebral vasoconstriction in toxemia. Neurology. 37:1987;1555-1557.
48. Working Group on High Blood Pressure in Pregnancy, 1990. Consensus report. Am. J. Obstet. Gynecol. 163, 1689-1712.
49. Zuspan F.P. Problems encountered in the treatment of pregnancy-induced hypertension. A point of view. Am. J. Obstet. Gynecol. 131:1978;591-597.